Q BioMed Inc (NASDAQ:QBIO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.
According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “
Q BioMed (NASDAQ:QBIO) opened at 3.27 on Wednesday. The firm’s 50-day moving average is $3.21 and its 200-day moving average is $3.08. Q BioMed has a 52-week low of $1.26 and a 52-week high of $6.00. The stock’s market cap is $29.70 million.
About Q BioMed
Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.